Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/26/16 → 03/24/18 |
Funding
- Eli Lilly and Company: $18,137.00
A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research